Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

US Compounding

US Compounding
2005 FOUNDED
M&A STATUS
71-80 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Operator of a drug compounding outsourcing facility. The company provides bespoke medications, such as corticosteroids and hormone replacement therapies in Conway, Arkansas.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Primary Office
  • P.O. Box 2709
  • Conway, AR 72033
  • United States

+1 (501) 000-0000

US Compounding Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore US Compounding‘s full profile, request access.

Request full access to PitchBook

US Compounding Executive Team (2)

Name Title Board
Seat
Contact
Info
Rick Allen Senior Director, Sales & Vice President, Sales
Becca Mitchell Vice President, Operations